Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 368

1.

Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: a review.

Arruda RM, Castro R, Sartori M, Girão MJ.

Curr Opin Obstet Gynecol. 2009 Oct;21(5):412-4. doi: 10.1097/GCO.0b013e32832fd28f. Review.

PMID:
19593131
2.

Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.

Arruda RM, Castro RA, Sousa GC, Sartori MG, Baracat EC, Girão MJ.

Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1055-61. doi: 10.1007/s00192-008-0586-y. Epub 2008 Mar 11.

PMID:
18330483
3.

Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.

Alhasso AA, McKinlay J, Patrick K, Stewart L.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003193. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD003193.

PMID:
17054163
4.

Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence.

van Gool JD, de Jong TP, Winkler-Seinstra P, Tamminen-Möbius T, Lax H, Hirche H, Nijman RJ, Hjälmås K, Jodal U, Bachmann H, Hoebeke P, Walle JV, Misselwitz J, John U, Bael A; European Bladder Dysfunction Study (EU BMH1-CT94-1006)..

Neurourol Urodyn. 2014 Jun;33(5):482-7. doi: 10.1002/nau.22446. Epub 2013 Jun 15.

PMID:
23775924
5.

Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.

Rai BP, Cody JD, Alhasso A, Stewart L.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD003193. doi: 10.1002/14651858.CD003193.pub4. Review.

PMID:
23235594
6.

The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children.

Bael A, Lax H, de Jong TP, Hoebeke P, Nijman RJ, Sixt R, Verhulst J, Hirche H, van Gool JD; European Bladder Dysfunction Study (European Union BMH1-CT94-1006)..

J Urol. 2008 Oct;180(4):1486-93; discussion 1494-5. doi: 10.1016/j.juro.2008.06.054. Epub 2008 Aug 16.

PMID:
18710726
8.

The impact of detrusor overactivity on the management of stress urinary incontinence in women.

Lai HH, Simon M, Boone TB.

Curr Urol Rep. 2006 Sep;7(5):354-62. Review.

PMID:
16959174
9.
10.

Overactive bladder: magnetic versus electrical stimulation.

Takahashi S, Kitamura T.

Curr Opin Obstet Gynecol. 2003 Oct;15(5):429-33. Review.

PMID:
14501247
11.

Oxybutynin in detrusor overactivity.

Diokno A, Ingber M.

Urol Clin North Am. 2006 Nov;33(4):439-45, vii. Review.

PMID:
17011379
12.

Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.

Ridout AE, Yoong W.

J Obstet Gynaecol. 2010 Feb;30(2):111-4. doi: 10.3109/01443610903428922. Review.

PMID:
20143965
13.

Current perspectives on management of urgency using bladder and behavioral training.

Burgio KL.

J Am Acad Nurse Pract. 2004 Oct;16(10 Suppl):4-7. Review.

PMID:
15543926
14.

Overactive bladder treatments in early phase clinical trials.

Colli E, Digesu GA, Olivieri L.

Expert Opin Investig Drugs. 2007 Jul;16(7):999-1007. Review.

PMID:
17594185
15.

A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation.

Karademir K, Baykal K, Sen B, Senkul T, Iseri C, Erden D.

Scand J Urol Nephrol. 2005;39(3):230-3.

PMID:
16118096
16.
17.

Electrical pelvic floor stimulation in the management of urinary incontinence due to neuropathic overactive bladder.

Ishigooka M, Hashimoto T, Izumiya K, Katoh T, Yaguchi H, Nakada T, Handa Y, Hoshimiya N.

Front Med Biol Eng. 1993;5(1):1-10.

PMID:
8323877
18.

Update on drugs for overactive bladder syndrome.

[No authors listed]

Drug Ther Bull. 2007 Jun;45(6):44-8. Review.

PMID:
17583229
19.

Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.

Staskin DR, Dmochowski RR, Sand PK, Macdiarmid SA, Caramelli KE, Thomas H, Hoel G.

J Urol. 2009 Apr;181(4):1764-72. doi: 10.1016/j.juro.2008.11.125. Epub 2009 Feb 23.

PMID:
19233423
20.

Urgency-free time interval as primary endpoint for evaluating the outcome of a randomized OAB treatment.

Wang AC, Chen MC, Kuo WY, Lin YH, Wang YC, Lo TS.

Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul;20(7):819-25. doi: 10.1007/s00192-009-0860-7. Epub 2009 Apr 10.

PMID:
19495544

Supplemental Content

Support Center